Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

Possible effects of pituitary adenylate cyclase activating polypeptide (PACAP) on early embryo implantation marker HB-EGF in mouse.

Somoskői B, Török D, Reglődi D, Tamás A, Fülöp BD, Cseh S.

Reprod Biol. 2020 Jan 18. pii: S1642-431X(19)30067-1. doi: 10.1016/j.repbio.2020.01.005. [Epub ahead of print]

PMID:
31964586
2.

Lack of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Disturbs Callus Formation.

Józsa G, Fülöp BD, Kovács L, Czibere B, Szegeczki V, Kiss T, Hajdú T, Tamás A, Helyes Z, Zákány R, Reglődi D, Juhász T.

J Mol Neurosci. 2019 Dec 5. doi: 10.1007/s12031-019-01448-z. [Epub ahead of print]

PMID:
31808034
3.

Age-related alterations of articular cartilage in pituitary adenylate cyclase-activating polypeptide (PACAP) gene-deficient mice.

Szegeczki V, Bauer B, Jüngling A, Fülöp BD, Vágó J, Perényi H, Tarantini S, Tamás A, Zákány R, Reglődi D, Juhász T.

Geroscience. 2019 Dec;41(6):775-793. doi: 10.1007/s11357-019-00097-9. Epub 2019 Oct 26.

4.

Hearing impairment and associated morphological changes in pituitary adenylate cyclase activating polypeptide (PACAP)-deficient mice.

Fulop DB, Humli V, Szepesy J, Ott V, Reglodi D, Gaszner B, Nemeth A, Szirmai A, Tamas L, Hashimoto H, Zelles T, Tamas A.

Sci Rep. 2019 Oct 10;9(1):14598. doi: 10.1038/s41598-019-50775-z.

5.

Pituitary Adenylate Cyclase-Activating Polypeptide-A Neuropeptide as Novel Treatment Option for Subacute Ileitis in Mice Harboring a Human Gut Microbiota.

Bereswill S, Escher U, Grunau A, Kühl AA, Dunay IR, Tamas A, Reglodi D, Heimesaat MM.

Front Immunol. 2019 Mar 22;10:554. doi: 10.3389/fimmu.2019.00554. eCollection 2019.

6.

Distribution of bioactive factors in human milk samples.

Vass RA, Kemeny A, Dergez T, Ertl T, Reglodi D, Jungling A, Tamas A.

Int Breastfeed J. 2019 Feb 11;14:9. doi: 10.1186/s13006-019-0203-3. eCollection 2019.

7.

VPAC1 receptors play a dominant role in PACAP-induced vasorelaxation in female mice.

Ivic I, Balasko M, Fulop BD, Hashimoto H, Toth G, Tamas A, Juhasz T, Koller A, Reglodi D, Solymár M.

PLoS One. 2019 Jan 25;14(1):e0211433. doi: 10.1371/journal.pone.0211433. eCollection 2019.

8.

Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Reduces Oxidative and Mechanical Stress-Evoked Matrix Degradation in Chondrifying Cell Cultures.

Szentléleky E, Szegeczki V, Karanyicz E, Hajdú T, Tamás A, Tóth G, Zákány R, Reglődi D, Juhász T.

Int J Mol Sci. 2019 Jan 4;20(1). pii: E168. doi: 10.3390/ijms20010168.

9.

Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide.

Atlasz T, Werling D, Song S, Szabo E, Vaczy A, Kovari P, Tamas A, Reglodi D, Yu R.

J Mol Neurosci. 2019 Jul;68(3):397-407. doi: 10.1007/s12031-018-1229-5. Epub 2018 Dec 12.

10.

Protective Effect of PACAP on Ischemia/Reperfusion-Induced Kidney Injury of Male and Female Rats: Gender Differences.

Laszlo E, Juhasz T, Varga A, Czibere B, Kovacs K, Degrell P, Horvath G, Jancso G, Szakaly P, Tamas A, Reglodi D.

J Mol Neurosci. 2019 Jul;68(3):408-419. doi: 10.1007/s12031-018-1207-y. Epub 2018 Nov 16.

PMID:
30443839
11.

Alternative Routes of Administration of the Neuroprotective Pituitary Adenylate Cyclase Activating Polypeptide.

Reglodi D, Atlasz T, Jungling A, Szabo E, Kovari P, Manavalan S, Tamas A.

Curr Pharm Des. 2018;24(33):3892-3904. doi: 10.2174/1381612824666181112110934. Review.

PMID:
30417775
12.

PACAP deficiency as a model of aging.

Reglodi D, Atlasz T, Szabo E, Jungling A, Tamas A, Juhasz T, Fulop BD, Bardosi A.

Geroscience. 2018 Dec;40(5-6):437-452. doi: 10.1007/s11357-018-0045-8. Epub 2018 Oct 22. Review.

13.

Signalling Alterations in Bones of Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Gene Deficient Mice.

Józsa G, Szegeczki V, Pálfi A, Kiss T, Helyes Z, Fülöp B, Cserháti C, Daróczi L, Tamás A, Zákány R, Reglődi D, Juhász T.

Int J Mol Sci. 2018 Aug 27;19(9). pii: E2538. doi: 10.3390/ijms19092538.

14.

Altered Notch Signaling in Developing Molar Teeth of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)-Deficient Mice.

Fulop BD, Sandor B, Szentleleky E, Karanyicz E, Reglodi D, Gaszner B, Zakany R, Hashimoto H, Juhasz T, Tamas A.

J Mol Neurosci. 2019 Jul;68(3):377-388. doi: 10.1007/s12031-018-1146-7. Epub 2018 Aug 10.

PMID:
30094580
15.

Accelerated pre-senile systemic amyloidosis in PACAP knockout mice - a protective role of PACAP in age-related degenerative processes.

Reglodi D, Jungling A, Longuespée R, Kriegsmann J, Casadonte R, Kriegsmann M, Juhasz T, Bardosi S, Tamas A, Fulop BD, Kovacs K, Nagy Z, Sparks J, Miseta A, Mazzucchelli G, Hashimoto H, Bardosi A.

J Pathol. 2018 Aug;245(4):478-490. doi: 10.1002/path.5100. Epub 2018 Jul 4.

16.

Presence and Effects of Pituitary Adenylate Cyclase Activating Polypeptide Under Physiological and Pathological Conditions in the Stomach.

Reglodi D, Illes A, Opper B, Schafer E, Tamas A, Horvath G.

Front Endocrinol (Lausanne). 2018 Mar 19;9:90. doi: 10.3389/fendo.2018.00090. eCollection 2018. Review.

17.

Protective effects of pituitary adenylate cyclase activating polypeptide against neurotoxic agents.

Reglodi D, Tamas A, Jungling A, Vaczy A, Rivnyak A, Fulop BD, Szabo E, Lubics A, Atlasz T.

Neurotoxicology. 2018 May;66:185-194. doi: 10.1016/j.neuro.2018.03.010. Epub 2018 Mar 28. Review.

PMID:
29604313
18.

Review on PACAP-Induced Transcriptomic and Proteomic Changes in Neuronal Development and Repair.

Rivnyak A, Kiss P, Tamas A, Balogh D, Reglodi D.

Int J Mol Sci. 2018 Mar 29;19(4). pii: E1020. doi: 10.3390/ijms19041020. Review.

19.

Pituitary adenylate cyclase-activating polypeptide ameliorates vascular dysfunction induced by hyperglycaemia.

Solymar M, Ivic I, Balasko M, Fulop BD, Toth G, Tamas A, Reman G, Koller A, Reglodi D.

Diab Vasc Dis Res. 2018 Jul;15(4):277-285. doi: 10.1177/1479164118757922. Epub 2018 Feb 21.

PMID:
29466879
20.

Examination of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) as a Potential Biomarker in Heart Failure Patients.

Sarszegi Z, Szabo D, Gaszner B, Konyi A, Reglodi D, Nemeth J, Lelesz B, Polgar B, Jungling A, Tamas A.

J Mol Neurosci. 2019 Jul;68(3):368-376. doi: 10.1007/s12031-017-1025-7. Epub 2018 Jan 20.

PMID:
29353438
21.

Alteration of the PAC1 Receptor Expression in the Basal Ganglia of MPTP-Induced Parkinsonian Macaque Monkeys.

Feher M, Gaszner B, Tamas A, Gil-Martinez AL, Fernandez-Villalba E, Herrero MT, Reglodi D.

Neurotox Res. 2018 May;33(4):702-715. doi: 10.1007/s12640-017-9841-7. Epub 2017 Dec 11.

PMID:
29230633
22.

Aging-Induced Modulation of Pituitary Adenylate Cyclase-Activating Peptide- and Vasoactive Intestinal Peptide-Induced Vasomotor Responses in the Arteries of Mice.

Ivic I, Solymar M, Fulop BD, Hashimoto H, Toth G, Tamas A, Juhasz T, Koller A, Reglodi D.

J Vasc Res. 2017;54(6):359-366. doi: 10.1159/000481781. Epub 2017 Nov 9.

PMID:
29131060
23.

Disturbed spermatogenic signaling in pituitary adenylate cyclase activating polypeptide-deficient mice.

Reglodi D, Cseh S, Somoskoi B, Fulop BD, Szentleleky E, Szegeczki V, Kovacs A, Varga A, Kiss P, Hashimoto H, Tamas A, Bardosi A, Manavalan S, Bako E, Zakany R, Juhasz T.

Reproduction. 2018 Feb;155(2):129-139. doi: 10.1530/REP-17-0470. Epub 2017 Nov 3.

PMID:
29101268
24.

Intestinal Microbiota Changes in Mice Lacking Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) - Bifidobacteria Make the Difference.

Heimesaat MM, Reifenberger G, Vicena V, Illes A, Horvath G, Tamas A, Fulop BD, Bereswill S, Reglodi D.

Eur J Microbiol Immunol (Bp). 2017 Sep 11;7(3):187-199. doi: 10.1556/1886.2017.00021. eCollection 2017 Sep.

25.

Changes in expression of neuropeptides and their receptors in the hypothalamus and gastrointestinal tract of calorie restricted hens.

Simon Á, Oláh J, Komlósi I, Jávor A, Németh J, Szilvássy Z, Reglődi D, Tamás A, Czeglédi L.

Acta Biol Hung. 2017 Sep;68(3):237-247. doi: 10.1556/018.68.2017.3.1.

PMID:
28901800
26.

Backup Mechanisms Maintain PACAP/VIP-Induced Arterial Relaxations in Pituitary Adenylate Cyclase-Activating Polypeptide-Deficient Mice.

Ivic I, Fulop BD, Juhasz T, Reglodi D, Toth G, Hashimoto H, Tamas A, Koller A.

J Vasc Res. 2017;54(3):180-192. doi: 10.1159/000457798. Epub 2017 May 11.

PMID:
28490016
27.

PACAP Protects Against Ethanol and Nicotine Toxicity in SH-SY5Y Cells: Implications for Drinking-Smoking Co-morbidity.

Manavalan S, Getachew B, Manaye KF, Khundmiri SJ, Csoka AB, McKinley R, Tamas A, Reglodi D, Tizabi Y.

Neurotox Res. 2017 Jul;32(1):8-13. doi: 10.1007/s12640-017-9727-8. Epub 2017 Mar 24.

PMID:
28342135
28.

Passage through the Ocular Barriers and Beneficial Effects in Retinal Ischemia of Topical Application of PACAP1-38 in Rodents.

Werling D, Banks WA, Salameh TS, Kvarik T, Kovacs LA, Vaczy A, Szabo E, Mayer F, Varga R, Tamas A, Toth G, Biro Z, Atlasz T, Reglodi D.

Int J Mol Sci. 2017 Mar 21;18(3). pii: E675. doi: 10.3390/ijms18030675.

29.

Effects of Postnatal Enriched Environment in a Model of Parkinson's Disease in Adult Rats.

Jungling A, Reglodi D, Karadi ZN, Horvath G, Farkas J, Gaszner B, Tamas A.

Int J Mol Sci. 2017 Feb 14;18(2). pii: E406. doi: 10.3390/ijms18020406.

30.

Accelerated retinal aging in PACAP knock-out mice.

Kovács-Valasek A, Szabadfi K, Dénes V, Szalontai B, Tamás A, Kiss P, Szabó A, Setalo G Jr, Reglődi D, Gábriel R.

Neuroscience. 2017 Apr 21;348:1-10. doi: 10.1016/j.neuroscience.2017.02.003. Epub 2017 Feb 13.

31.

Early Neurobehavioral Development of Mice Lacking Endogenous PACAP.

Farkas J, Sandor B, Tamas A, Kiss P, Hashimoto H, Nagy AD, Fulop BD, Juhasz T, Manavalan S, Reglodi D.

J Mol Neurosci. 2017 Apr;61(4):468-478. doi: 10.1007/s12031-017-0887-z. Epub 2017 Feb 6.

PMID:
28168413
32.

Pituitary adenylate cyclase-activating polypeptide (PACAP) has a neuroprotective function in dopamine-based neurodegeneration in rat and snail parkinsonian models.

Maasz G, Zrinyi Z, Reglodi D, Petrovics D, Rivnyak A, Kiss T, Jungling A, Tamas A, Pirger Z.

Dis Model Mech. 2017 Feb 1;10(2):127-139. doi: 10.1242/dmm.027185. Epub 2016 Dec 22.

33.

Ocular Delivery of PACAP1-27 Protects the Retina From Ischemic Damage in Rodents.

Werling D, Reglodi D, Banks WA, Salameh TS, Kovacs K, Kvarik T, Vaczy A, Kovacs L, Mayer F, Danyadi B, Lokos E, Tamas A, Toth G, Biro Z, Atlasz T.

Invest Ophthalmol Vis Sci. 2016 Dec 1;57(15):6683-6691. doi: 10.1167/iovs.16-20630.

PMID:
27936470
34.

The Protective Role of PAC1-Receptor Agonist Maxadilan in BCCAO-Induced Retinal Degeneration.

Vaczy A, Reglodi D, Somoskeoy T, Kovacs K, Lokos E, Szabo E, Tamas A, Atlasz T.

J Mol Neurosci. 2016 Oct;60(2):186-94. doi: 10.1007/s12031-016-0818-4. Epub 2016 Aug 26.

PMID:
27566170
35.

PACAP Is Protective in a Rat Model of Retinopathy of Prematurity.

Kvarik T, Mammel B, Reglodi D, Kovacs K, Werling D, Bede B, Vaczy A, Fabian E, Toth G, Kiss P, Tamas A, Ertl T, Gyarmati J, Atlasz T.

J Mol Neurosci. 2016 Oct;60(2):179-85. doi: 10.1007/s12031-016-0797-5. Epub 2016 Aug 25.

PMID:
27561927
36.

Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Oxidative Stress in Zebrafish Hair Cells.

Kasica N, Podlasz P, Sundvik M, Tamas A, Reglodi D, Kaleczyc J.

Neurotox Res. 2016 Nov;30(4):633-647. Epub 2016 Aug 24.

37.

Structural and Morphometric Comparison of Lower Incisors in PACAP-Deficient and Wild-Type Mice.

Sandor B, Fintor K, Reglodi D, Fulop DB, Helyes Z, Szanto I, Nagy P, Hashimoto H, Tamas A.

J Mol Neurosci. 2016 Jun;59(2):300-8. doi: 10.1007/s12031-016-0765-0. Epub 2016 May 6.

PMID:
27154515
38.

Pituitary Adenylate Cyclase Activating Polypeptide, A Potential Therapeutic Agent for Diabetic Retinopathy in Rats: Focus on the Vertical Information Processing Pathway.

Szabadfi K, Reglodi D, Szabo A, Szalontai B, Valasek A, Setalo G Jr, Kiss P, Tamas A, Wilhelm M, Gabriel R.

Neurotox Res. 2016 Apr;29(3):432-46. doi: 10.1007/s12640-015-9593-1. Epub 2016 Jan 6.

PMID:
26739825
39.

Bowel elastography - a pilot study for developing an elastographic scoring system to evaluate disease activity in pediatric Crohn's disease.

Fufezan O, Asavoaie C, Tamas A, Farcau D, Serban D.

Med Ultrason. 2015 Dec;17(4):422-30. doi: 10.11152/mu.2013.2066.174.bwe.

40.

Novel tactics for neuroprotection in Parkinson's disease: Role of antibiotics, polyphenols and neuropeptides.

Reglodi D, Renaud J, Tamas A, Tizabi Y, Socías SB, Del-Bel E, Raisman-Vozari R.

Prog Neurobiol. 2017 Aug;155:120-148. doi: 10.1016/j.pneurobio.2015.10.004. Epub 2015 Nov 2. Review.

PMID:
26542398
41.

Examination of PACAP-Like Immunoreactivity in Urogenital Tumor Samples.

Tamas A, Javorhazy A, Reglodi D, Sarlos DP, Banyai D, Semjen D, Nemeth J, Lelesz B, Fulop DB, Szanto Z.

J Mol Neurosci. 2016 Jun;59(2):177-83. doi: 10.1007/s12031-015-0652-0. Epub 2015 Oct 10.

PMID:
26454744
42.

Ischemia/reperfusion-induced Kidney Injury in Heterozygous PACAP-deficient Mice.

Laszlo E, Varga A, Kovacs K, Jancso G, Kiss P, Tamas A, Szakaly P, Fulop B, Reglodi D.

Transplant Proc. 2015 Sep;47(7):2210-5. doi: 10.1016/j.transproceed.2015.07.027.

PMID:
26361682
43.

Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Pathway Is Induced by Mechanical Load and Reduces the Activity of Hedgehog Signaling in Chondrogenic Micromass Cell Cultures.

Juhász T, Szentléleky E, Somogyi CS, Takács R, Dobrosi N, Engler M, Tamás A, Reglődi D, Zákány R.

Int J Mol Sci. 2015 Jul 29;16(8):17344-67. doi: 10.3390/ijms160817344.

44.

Environmental enrichment increases PACAP levels in the CNS of adult rats.

Horvath G, Kiss P, Nemeth J, Lelesz B, Tamas A, Reglodi D.

Neuro Endocrinol Lett. 2015;36(2):143-7.

PMID:
26071583
45.

Retinal aging in the diurnal Chilean rodent (Octodon degus): histological, ultrastructural and neurochemical alterations of the vertical information processing pathway.

Szabadfi K, Estrada C, Fernandez-Villalba E, Tarragon E, Setalo G Jr, Izura V, Reglodi D, Tamas A, Gabriel R, Herrero MT.

Front Cell Neurosci. 2015 Apr 21;9:126. doi: 10.3389/fncel.2015.00126. eCollection 2015.

46.

Atomoxetine reverses locomotor hyperactivity, impaired novel object recognition, and prepulse inhibition impairment in mice lacking pituitary adenylate cyclase-activating polypeptide.

Shibasaki Y, Hayata-Takano A, Hazama K, Nakazawa T, Shintani N, Kasai A, Nagayasu K, Hashimoto R, Tanida M, Katayama T, Matsuzaki S, Yamada K, Taniike M, Onaka Y, Ago Y, Waschek JA, Köves K, Reglődi D, Tamas A, Matsuda T, Baba A, Hashimoto H.

Neuroscience. 2015 Jun 25;297:95-104. doi: 10.1016/j.neuroscience.2015.03.062. Epub 2015 Apr 1.

PMID:
25841321
47.

Diagnostic accuracy of controlled attenuation parameter measured by transient elastography for the non-invasive assessment of liver steatosis: a prospective study.

Lupșor-Platon M, Feier D, Stefănescu H, Tamas A, Botan E, Sparchez Z, Maniu A, Badea R.

J Gastrointestin Liver Dis. 2015 Mar;24(1):35-42. doi: 10.15403/jgld.2014.1121.mlp.

48.

PACAP and VIP signaling in chondrogenesis and osteogenesis.

Juhász T, Helgadottir SL, Tamás A, Reglődi D, Zákány R.

Peptides. 2015 Apr;66:51-7. doi: 10.1016/j.peptides.2015.02.001. Epub 2015 Feb 19. Review.

PMID:
25701761
49.

Neurochemical changes in different brain regions induced by PACAP - relations to neuroprotection.

Reglodi D, Maasz G, Pirger Z, Rivnyak A, Balogh D, Jungling A, Fulop B, Mark L, Tamas A.

Springerplus. 2015 Jun 12;4(Suppl 1):L56. doi: 10.1186/2193-1801-4-S1-L56. eCollection 2015. No abstract available.

50.

The effects of pituitary adenylate cyclase activating polypeptide in renal ischemia/reperfusion.

László E, Kiss P, Horváth G, Szakály P, Tamás A, Reglődi D.

Acta Biol Hung. 2014 Dec;65(4):369-78. doi: 10.1556/ABiol.65.2014.4.1. Review.

PMID:
25475976

Supplemental Content

Support Center